Page last updated: 2024-08-23

dobutamine and losartan potassium

dobutamine has been researched along with losartan potassium in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allegra, A; Aloisi, C; Buemi, M; Corica, F; Frisina, N; Galasso, A; Laganà, A; Siracusano, L1
Becker, T; Freudenthaler, S; Gleiter, CH; Gundert-Remy, U; Schreeb, KH1

Trials

1 trial(s) available for dobutamine and losartan potassium

ArticleYear
Fenoterol but not dobutamine increases erythropoietin production in humans.
    Clinical pharmacology and therapeutics, 1997, Volume: 61, Issue:6

    Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cyclic AMP; Dobutamine; Erythropoiesis; Erythropoietin; Fenoterol; Hematocrit; Hemoglobins; Humans; Kidney; Male; Phlebotomy; Renin; Single-Blind Method

1997

Other Studies

1 other study(ies) available for dobutamine and losartan potassium

ArticleYear
Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock.
    Nephron, 1996, Volume: 74, Issue:2

    Topics: Dobutamine; Dopamine; Erythropoietin; Fatal Outcome; Female; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Artery; Recombinant Proteins; Shock; Vascular Resistance

1996